However, aside from FASN, other enzymes involved in de novo FA synthesis also play an instrumental part in tumour progression, such as ACC, the rate-limiting enzyme for de novo FA synthesis, and ACLY, which provides glucose-derived acetyl-CoA as the main substrate for both ACC and FASN (Figure 1). This evidence concerns the gene FASN and neoplasm.